Details of Host Protein-DME Interaction (HOSPPI)
General Information of Drug-Metabolizing Enzyme (DME ID: DME1091) | |||||
---|---|---|---|---|---|
DME Name | Kanamycin/gentamycin-resistance enzyme (aacA), Campylobacter coli | DME Info | |||
UniProt ID | |||||
EC Number | EC: 2.7.1.190 (Click to Show/Hide the Complete EC Tree) | ||||
Lineage | Species: Campylobacter coli (Click to Show/Hide the Complete Species Lineage) | ||||
Interactome |
Disease Specific Interactions between Host Protein and DME (HOSPPI) | |||||
---|---|---|---|---|---|
Drug co-metabolism | |||||
Cometabolized drug: Tobramycin | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
RNA cytidine acetyltransferase (hALP) | Click to Show/Hide the Cometabolization Info | ||||
DME ID | DME0007 DME Info | ||||
Uniprot ID | |||||
Interaction Name | hALP-aacA interaction | [1], [2] | |||
Description | The interaction, between human RNA cytidine acetyltransferase and Kanamycin/gentamycin-resistance enzyme from Campylobacter coli which collectively metabolize the drug Tobramycin, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.